Wells Fargo
AGN.PRA

Wells Fargo’s Allergan plc AGN.PRA Stock Holding History

Wells Fargo’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,672
Closed -$15.1M – 6755
2017
Q4 		$15.1M Buy
25,672
+10,898
+74% +$7.03M ﹤0.01% 1677
2017
Q3 		$10.9M Buy
14,774
+4,618
+45% +$3.83M ﹤0.01% 1900
2017
Q2 		$8.81M Sell
10,156
-8,141
-44% -$6.82M ﹤0.01% 2008
2017
Q1 		$15.5M Sell
18,297
-39,586
-68% -$32.8M 0.01% 1542
2016
Q4 		$44.1M Sell
57,883
-4,156
-7% -$3.14M 0.02% 900
2016
Q3 		$51M Sell
62,039
-972
-2% -$840K 0.02% 774
2016
Q2 		$52.5M Buy
63,011
+16,603
+36% +$13.9M 0.02% 730
2016
Q1 		$42.7M Sell
46,408
-4,107
-8% -$3.93M 0.02% 848
2015
Q4 		$52M Buy
50,515
+13,267
+36% +$13.3M 0.02% 751
2015
Q3 		$35.1M Buy
37,248
+13,913
+60% +$14.5M 0.01% 943
2015
Q2 		$24.4M Buy
+23,335
New +$24.4M 0.01% 1237

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Wells Fargo's AGN.PRA Position: Q1 2018 in Review

Wells Fargo sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 25,672 shares — an estimated $15.1M sold.

Wells Fargo first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $52.5M in Q2 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Wells Fargo reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Wells Fargo sold 25,672 Allergan plc shares in Q1 2018, an estimated $15.1M.
  • Wells Fargo first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Wells Fargo's Allergan plc position peaked at $52.5M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Wells Fargo's 13F filing for Q1 2018, filed 2 May 2018.